Indonesia approves home-grown COVID-19 vaccine

Indonesia’s Food and Drug Supervisory Agency (BPOM) has issued emergency use authorisation (EUA) for  IndoVac COVID-19 vaccine produced by state-owned pharmaceutical company PT Bio Farma.

 

Addressing a recent press conference, BPOM Head Penny K. Lukito said that the IndoVac vaccine was produced for use as a booster shot.

 

Earlier, PT Bio Farma President Director Honesti Basyir said that the company is ready to produce 20 million doses of this vaccine in the initial stage. The figure can be further increased to 100 million doses per year by 2024.

 

IndoVac’s clinical trials showed that the vaccine had good efficacy in increasing antibody concentration and guaranteeing the body’s safety.

 

Moreover, during immuno-bridging trials with comparison vaccines, the IndoVac vaccine had better effectiveness than them, with an efficacy of above 80%./.

Source: Vietnam News Agency

  • web Desk

    Related Posts

    Ambassadors pay tribute to Vietnamese Party Chief

    Ambassadors to Vietnam from different countries and representatives of international organisations wrote in the condolence book to pay tribute to Party General Secretary Nguyen Phu Trong at the Government Guest…

    Agencies and organisations pay tribute to Party leader Nguyen Phu Trong

    The respect-paying ceremony for General Secretary of the Communist Party of Vietnam Central Committee Nguyen Phu Trong, who passed away on July 19 at the age of 80, is taking…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.